Moelis & Company Announces Kasim Kutay has Joined as a Managing Director in Healthcare
Moelis & Company Announces Kasim Kutay has Joined as a Managing Director in Healthcare
Moelis & Company announced today that Kasim Kutay has joined the firm as a Managing Director based in London. Mr. Kutay, who has 20 years of investment banking experience, will lead the development of the firm’s European Healthcare practice and provide advisory services to certain other clients in the EMEA region.
“Growing our global business is top of mind for Moelis & Company, as demonstrated by the four major hires we have announced in London in less than two weeks,” said Ken Moelis, Chief Executive Officer of Moelis & Company. “We will continue to add world class talent like Kasim to enhance our ability to deliver outstanding, independent advice to clients.”
Mr. Kutay has a long career of providing advice to healthcare companies and spent 18 years at Morgan Stanley, where he was most recently Chairman of the European Healthcare Group. While at Morgan Stanley, Mr. Kutay managed a leading franchise advising healthcare companies on the full spectrum of corporate finance matters including mergers and acquisitions, initial public offerings and other debt and equity financings. Prior to joining Moelis & Company, Mr. Kutay was a Managing Director and Head of the Financial Solutions Group at SUN Group Advisors.
“Kasim brings tremendous experience and an extensive relationship network in the healthcare market that will be extremely valuable to our clients in this sector,” said Mark Aedy, Head of Europe, Middle East and Africa. “He will also help Moelis & Company broaden our franchise in other sectors and regions, including the Middle East, and we are thrilled to have him on board.”
Kasim Kutay commented, “I am very excited about Moelis & Company’s commitment to the healthcare sector, as evidenced by its recent senior hires in the United States. This is a firm with serious momentum, and I look forward to working with Mark and the team to enhance our global Healthcare practice and help build our European franchise.”
About Moelis & Company
Moelis & Company is an investment bank that provides financial advisory services and capital raising solutions to clients in connection with mergers and acquisitions, restructurings and other strategic matters. The firm also manages investment funds that integrate capital with its advisory expertise. Moelis & Company serves a broad client base through its offices in New York, London, Boston, Chicago and Los Angeles. For more information, please visit www.moelis.com .
Note to Editors
1. On 22nd April, Moelis & Company announced that Mark Aedy will join the firm in June as Head of Europe, Middle East and Africa Investment Banking.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Contact:
Moelis & Company
Kate
Pilcher, +1 212-880-7307
or
Brunswick
Group
Jonathan Glass, Helen Barnes, +44 207 404 5959
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
RTL Luxembourg Expands Deployment of Verimatrix Technologies to Protect Premier Auto Racing Against Piracy11.9.2025 17:45:00 CEST | Press release
RTL’s high-value motorsport racing content now harnesses Verimatrix Counterspy, Deepscan and Watermarking solutions to put them fully in control of their content Regulatory News: Verimatrix, (Euronext Paris: VMX), a leading provider of security solutions for a safer connected world, today announced that RTL Luxembourg, the country’s leading media company, has further expanded its use of Verimatrix anti-piracy tools to now include the full Streamkeeper suite of solutions. Initially deploying Streamkeeper Multi-DRM, RTL Luxembourg also recently implemented Counterspy, Deepscan and Watermarking solutions – the industry’s latest set of powerful tools that help further bolster proactive protections for RTL’s motorsport content revenue. It was announced in April 2024 that RTL Luxembourg selected Verimatrix Streamkeeper Multi-DRM to ensure that RTL Luxembourg remained in full control of its valuable digital assets while also consistently keeping costs low and preventing unneeded technical com
Xylem and Amazon Partner on Smart Water Upgrades to Save More Than 1.3 Billion Liters Annually in Mexico11.9.2025 16:00:00 CEST | Press release
Advanced water technology helps Mexico City and Monterrey reduce leaks and improve supply for thousands of residents Residents in Mexico City and Monterrey will soon enjoy more reliable water supply as the two cities launch groundbreaking infrastructure upgrades to save over 1.3 billion liters of water a year – easing pressure from the rapid urbanization and persistent drought conditions that have strained local water systems. The two cities are working in partnership with global water technology company Xylem (NYSE: XYL) and Amazon (NASDAQ: AMZN) to deploy Xylem Vue, an advanced software platform that applies data and analytics to detect leaks, cut water losses and improve residents’ water supply. The projects are estimated to save upwards of 800 million liters of water a year in Mexico City and 560 million liters a year in Monterrey. “In a water-stressed region, where every liter counts, recovering more than a billion liters of water each year is a game-changer,” said Jaime Barba, Ge
HTEC Partners with World Economic Forum11.9.2025 15:56:00 CEST | Press release
HTEC to bring AI expertise to contribute toindustry transformation and real-world outcomes HTEC, a global digital engineering and product development company, has today announced that it has joined the World Economic Forum’s (WEF) Centre for AI Excellence. HTEC will contribute to the community through its expertise and thought leadership to help advance AI adoption and AI innovation across its core industries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250911910448/en/ HTEC Partners with World Economic Forum to bring AI expertise to help with industry transformation and real-world outcomes WEF’s Centre for AI Excellence is bringing together leading industry organisations and experts to work together to advance the pace and positive impact AI can have in economies and societies. Its goal is to unlock transformative potential in an equitable and human-centered way, which is well aligned with HTEC’s principles and values. A
Alipay Tap! Users Reach 200 Million, Expands to Over 1,000 Scenarios Beyond Payments11.9.2025 15:31:00 CEST | Press release
Alipay Tap! now supports over 1,000 everyday scenarios, making payments and customer interactions faster and simpler with just a tap.The company also launched its first AI-powered payment service in Luckin Coffee’s app, enabling hassle-free ordering and payment via voice commands to AI agents for the first time. Alipay announced today at the 2025 INCLUSION · Conference on the Bund in Shanghai that its QR code-based contactless payment and engagement solution, Alipay Tap!, has rapidly grown its user base to 200 million since its launch in China in June 2024. The milestone comes just months after surpassing 100 million users in April 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250911881010/en/ With Alipay Tap!, users can open a vending machine with a simple tap Designed to be simpler than QR code scanning, Alipay Tap! lets users complete a transaction or access a service by simply tapping their unlocked phone on a mer
Vertex Scientists Awarded the 2025 Lasker~DeBakey Clinical Medical Research Award for Pioneering Discoveries in Cystic Fibrosis11.9.2025 15:05:00 CEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Senior Vice President Paul Negulescu has been named as one of the winners of this year’s Lasker~DeBakey Clinical Medical Research Award for his role “in the development of a novel, life-saving treatment for cystic fibrosis (CF) — namely, a triple-drug combination therapy, TRIKAFTA®, that has helped countless people with this genetic disease.” Dr. Negulescu is one of three awardees, alongside Jesús (Tito) González, a former Vertex scientist, and Michael Welsh, Professor of Internal Medicine-Pulmonary, Critical Care and Occupational Medicine, University of Iowa. The prize honors the groundbreaking work of Dr. Negulescu, Dr. González and the entire Vertex team who discovered and developed the first and only approved medicines that address the underlying cause of CF. To date, Vertex has brought five transformational medicines to patients with CF which have fundamentally changed the way this disease is treated. “I’m hon
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom